Use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus
AssigneesDistributors Processing, Inc., Dantrace-Danfeed Ivs
InventorJens Jorgen Pedersen
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus and dietary supplements for mammals comprising zinc and copper gluconate and their use in treatment of methicillin-resistant staphylococcus aureus.
Claims25
Zinc gluconate and copper gluconate for oral use in the treatment of methicillin-resistant staphylococcus aureus in mammals, wherein said mammal belongs to the genus Sus of the Suidae family.
(canceled)
6-11. (canceled)
15-23. (canceled)
A method of treatment of methicillin-resistant staphylococcus aureus in mammals comprising oral administration of zinc gluconate and copper gluconate, wherein said mammals belong to the genus Sus of the Suidae family.
(canceled)
29-34. (canceled)
37-51. (canceled)
Dependencies are inferred from the claim text.